- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Russian Company Building Europe's Largest Biopharmaceutical Plant

© Sputnik / Sergey Pyatakov / Go to the mediabankPills packed at a blister machine. File photo
Pills packed at a blister machine. File photo - Sputnik International
Subscribe
A Russian pharmaceutical company has begun building Europe's largest biopharmaceutical plant, with plans not only for import substitution but also export to Western countries.

Russian pharmaceutical company Generium has begun building Europe's largest biopharmaceutical plant in the country's Vladimir region, according to Russian media.

The plant is scheduled to be completed in 2018. The company partnered with Canada's ProMetic Life Science for equipment solutions. The company plans to export its production from the plant to the US, Canada and European countries. The new plant will produce biopharmaceuticals including antibodies, blood coagulants and albumin, a more effective treatment for patients with low blood volume than saline solution.

"The plant, beginning from the design stage, takes into account all modern requirements of both European regulating bodies (EMEA) and FDA, the body responsible for regulating pharmaceutical companies in the US," a representative of the company told Russian news site Lenta.ru.

We may soon have a small antenna implanted into our bodies to report on our vital statistics. - Sputnik International
Doctors Eye Implantable Body Antenna for Long-Term Monitoring
Generium is also taking part in the Russian government's "Pharma-2020" strategy of pharmaceutical import substitution adopted in 2008. On Monday the company announced the creation of a new drug treatment for hemophilia, which it promised would reduce the cost of currently largely imported treatments by half.

In October 2014, Generium also began exporting its pharmaceutical drugs to China, after an agreement with China's largest state pharmaceutical company, Sinopharm.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала